Skip to content
Biodatica
Start free

Investigator

Michael S Gilmore

MASSACHUSETTS EYE AND EAR INFIRMARY · funded by NIAID

Companies
4

Resolved onto their grants.

Grants
6

Federal awards on file.

Non-dilutive funding
$5.5M

Summed across those awards.

First award
Sep 1, 2009

On this record.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. P01

    Subproject 3: Unique Features of Enterococcus that Confer Intrinsic Resistance

    $274k

    Sep 1, 2009NIAIDMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11014067 (opens the source filing in a new tab)

  2. P01

    Administrative Core

    $147k

    Sep 1, 2009NIAIDMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11014042 (opens the source filing in a new tab)

  3. P01

    Harvard-wide Program on Antibiotic Resistance

    $2.3M

    Sep 1, 2009NIAIDMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11014041 (opens the source filing in a new tab)

  4. P01

    Subproject 3: Unique Features of Enterococcus that Confer Intrinsic Resistance

    $407k

    Sep 1, 2009NIAIDMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11299028 (opens the source filing in a new tab)

  5. P01

    Harvard-wide Program on Antibiotic Resistance

    $2.2M

    Sep 1, 2009NIAIDMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11299014 (opens the source filing in a new tab)

  6. P01

    Administrative Core

    $221k

    Sep 1, 2009NIAIDMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11299015 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources